DanLit888 OP Go to moon : Currently at 75, the reason for establishing a position is that nvo has entered the oversold zone, dropping nearly 50% from its high point. Additionally, in the current market environment, the weight loss drug is not as effective as Eli Lilly and Co, which is not a US-based company, facing the impact of medical insurance price reduction on expected revenue. The stock price has now only returned to a reasonable level - it was previously too expensive. If it continues to drop, I will continue to buy, and if buying now, be prepared for long-term holding, as returning to the previous high point may take 1-2 years.

DanLit888 : This is a Brazilian company. Interest rate cuts have no impact.